genesis
161 employees on LinkedIn · 6 known investors
Find your way into genesis
1,314 people in our graph share verified history with the genesis team — schools, employers, funds. One of them is your warm intro.
Deep Nisharunlockedknows Evan Feinberg · together at Stanford University (overlapped)
×9knows the team · via Stanford University
×2knows the team · via Yale University
Genesis Therapeutics applies artificial intelligence to discover and develop drugs for challenging targets, combining machine learning with biotech research. It operates in the AI-driven drug discovery space.
Founders & leadership
EF
Evan FeinberginFounderEvan Feinberg holds a Ph.D. from Stanford where he worked with Vijay Pande on deep learning methods for molecular property prediction, and previously served as a deep learning consultant at Merck; he studied applied physics at Yale and is now founder of Genesis Therapeutics, which uses AI for drug discovery and development.
BS
Ben SklaroffinFounder
Investors · 6
Frequently asked questions
- What does genesis do?
- Genesis Therapeutics applies artificial intelligence to discover and develop drugs for challenging targets, combining machine learning with biotech research. It operates in the AI-driven drug discovery space.
- Who founded genesis?
- genesis was founded by Evan Feinberg, Ben Sklaroff.
- Who are genesis's investors?
- genesis's investors include Andreessen Horowitz, BlackRock, Open Field Capital, Ulu Ventures, Mana Ventures, NVentures.